experiment 620 words
Contents

Frontal and Temporal Lobe Selective Vulnerability in FTD — Mechanisms and Therapeutic Targets

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (37)

Cross-Seeding Prevention Strategy
Score: 0.69
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.69
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.68
R-Loop Resolution Enhancement Therapy
Score: 0.68
Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.68
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
RNA Granule Nucleation Site Modulation
Score: 0.66
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.65
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.62
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
LRP1-Dependent Tau Uptake Disruption
Score: 0.60
VCP-Mediated Autophagy Enhancement
Score: 0.59
Temporal Decoupling via Circadian Clock Reset
Score: 0.54
Lysosomal Membrane Repair Enhancement
Score: 0.54
Cryptic Exon Silencing Restoration
Score: 0.53
← Prevpg 2/2

Related Analyses (30)

RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed

Related Experiments (16)

Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40

See Also (15)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: co_discussed
ABCD3 Gene
gene · KG edge: activates
Packard Center for ALS Research
institution · KG edge: accumulates_in
MAPK Signaling Pathways in Neurodegeneration
mechanism · KG edge: associated_with
Actin Cytoskeleton Dynamics in Neurodegeneration
mechanism · KG edge: co_discussed

Knowledge Graph (8 edges)

GRN expressed_in Frontal Lobe
MAPT expressed_in Frontal Lobe
C9ORF72 expressed_in Frontal Lobe
MTOR expressed_in Frontal Lobe
RHEB expressed_in Frontal Lobe
CAMK2A expressed_in Frontal Lobe
Neural Progenitor expressed_in Frontal Lobe
NDUFS6 expressed_in Frontal Lobe

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.